Publications by authors named "Elizabeth Raupach"

Article Synopsis
  • Vesiculoviruses are promising candidates for cancer treatment due to their rapid replication and ability to target tumors effectively while avoiding immune system detection.
  • Researchers developed a synthetic chimeric virus called VMG, which combines elements from Morreton virus and vesicular stomatitis virus, and found it effectively induced cell death in various sarcoma types across different species.
  • Initial safety tests in healthy mice showed no toxicity, and while VMG didn't suppress tumors in one model, it successfully stimulated immune responses, showing potential as a new oncolytic virotherapy for sarcoma.
View Article and Find Full Text PDF

Background: Morreton virus (MORV) is an oncolytic Vesiculovirus , genetically distinct from vesicular stomatitis virus (VSV).

Aim: To report that MORV induced potent cytopathic effects (CPEs) in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) in vitro models.

Approach And Results: In preliminary safety analyses, high intranasal doses (up to 10 10 50% tissue culture infectious dose [TCID 50 ]) of MORV were not associated with significant adverse effects in immune competent, non-tumor-bearing mice.

View Article and Find Full Text PDF

The robust detection of disease-associated splice events from RNAseq data is challenging due to the potential confounding effect of gene expression levels and the often limited number of patients with relevant RNAseq data. Here we present a novel statistical approach to splicing outlier detection and differential splicing analysis. Our approach tests for differences in the percentages of sequence reads representing local splice events.

View Article and Find Full Text PDF

Cell-free DNA (cfDNA) in urine is a promising analyte for noninvasive diagnostics. However, urine cfDNA is highly fragmented. Whether characteristics of these fragments reflect underlying genomic architecture is unknown.

View Article and Find Full Text PDF

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer. SCCOHT tumors have inactivating mutations in (BRG1), one of the two mutually exclusive ATPases of the SWI/SNF chromatin remodeling complex. To address the role that BRG1 loss plays in SCCOHT tumorigenesis, we performed integrative multi-omic analyses in SCCOHT cell lines +/- BRG1 reexpression.

View Article and Find Full Text PDF

The Polymerase Associated Factor 1 complex (Paf1C) is a multifunctional regulator of eukaryotic gene expression important for the coordination of transcription with chromatin modification and post-transcriptional processes. In this study, we investigated the extent to which the functions of Paf1C combine to regulate the transcriptome. While previous studies focused on the roles of Paf1C in controlling mRNA levels, here, we took advantage of a genetic background that enriches for unstable transcripts, and demonstrate that deletion of affects all classes of Pol II transcripts including multiple classes of noncoding RNAs (ncRNAs).

View Article and Find Full Text PDF
Article Synopsis
  • Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive ovarian cancer affecting young women, primarily caused by the loss of specific protein subunits (SMARCA4 and SMARCA2).
  • Researchers performed extensive drug screenings and identified ponatinib, a receptor tyrosine kinase (RTK) inhibitor, as the most effective treatment for SCCOHT, showing selectivity against cancer cells compared to normal cells.
  • In preclinical models, ponatinib significantly reduced tumor growth and volume, leading to suggestions for clinical trials to explore its effectiveness in treating SCCOHT in patients.
View Article and Find Full Text PDF

Transcription of nonprotein-coding DNA is widespread in eukaryotes and plays important regulatory roles for many genes, including genes that are misregulated in cancer cells. Its pervasiveness presents the potential for a wealth of diverse regulatory roles for noncoding transcription. We previously showed that the act of transcribing noncoding DNA (ncDNA) across the promoter of the protein-coding SER3 gene in Saccharomyces cerevisiae positions nucleosomes over the upstream activating sequences, leading to strong repression of SER3 transcription.

View Article and Find Full Text PDF